Clinical Trial Update: IBP-9414 for the Prevention of Necrotizing Enterocolitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for IBP-9414 in preventing necrotizing enterocolitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• IBP-9414

Snippet

Sponsor: Infant Bacterial Therapeutics | Conditions: Necrotizing Enterocolitis | Phase 2 | Status: COMPLETED